Skye Bioscience Statistics

Total Valuation

SKYE has a market cap or net worth of $165.04 million. The enterprise value is $95.99 million.

Market Cap	165.04M
Enterprise Value	95.99M

Important Dates

The next confirmed earnings date is Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

SKYE has 30.34 million shares outstanding. The number of shares has increased by 592.34% in one year.

Shares Outstanding	30.34M
Shares Change (YoY)	+592.34%
Shares Change (QoQ)	+38.11%
Owned by Insiders (%)	0.36%
Owned by Institutions (%)	48.11%
Float	17.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.10
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.07.

Current Ratio	6.07
Quick Ratio	5.21
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.94

Financial Efficiency

Return on equity (ROE) is -130.08% and return on invested capital (ROIC) is -39.27%.

Return on Equity (ROE)	-130.08%
Return on Assets (ROA)	-30.92%
Return on Capital (ROIC)	-39.27%
Revenue Per Employee	n/a
Profits Per Employee	-$3.84M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SKYE has paid $10,071 in taxes.

Income Tax	10,071
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +220.00% in the last 52 weeks. The beta is 1.75, so SKYE's price volatility has been higher than the market average.

Beta (5Y)	1.75
52-Week Price Change	+220.00%
50-Day Moving Average	4.94
200-Day Moving Average	8.27
Relative Strength Index (RSI)	61.49
Average Volume (20 Days)	250,147

Short Selling Information

The latest short interest is 1.42 million, so 4.67% of the outstanding shares have been sold short.

Short Interest	1.42M
Short Previous Month	1.21M
Short % of Shares Out	4.67%
Short % of Float	8.13%
Short Ratio (days to cover)	2.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.14M
Pretax Income	-42.28M
Net Income	-42.29M
EBITDA	-22.02M
EBIT	-22.14M
Earnings Per Share (EPS)	-$1.95

Full Income Statement

Balance Sheet

The company has $74.12 million in cash and $5.07 million in debt, giving a net cash position of $69.05 million or $2.28 per share.

Cash & Cash Equivalents	74.12M
Total Debt	5.07M
Net Cash	69.05M
Net Cash Per Share	$2.28
Equity (Book Value)	72.81M
Book Value Per Share	2.59
Working Capital	72.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.70 million and capital expenditures -$46,334, giving a free cash flow of -$19.75 million.

Operating Cash Flow	-19.70M
Capital Expenditures	-46,334
Free Cash Flow	-19.75M
FCF Per Share	-$0.65

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SKYE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-592.34%
Shareholder Yield	-592.34%
Earnings Yield	-25.62%
FCF Yield	-11.97%

Analyst Forecast

The average price target for SKYE is $18.67, which is 243.20% higher than the current price. The consensus rating is "Buy".

Price Target	$18.67
Price Target Difference	243.20%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-16.02%

Stock Forecasts

Stock Splits

The last stock split was on September 8, 2023. It was a reverse split with a ratio of 0.004:1.

Last Split Date	Sep 8, 2023
Split Type	Reverse
Split Ratio	0.004:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2